Development of a validated LC-MS/MS method for the in vitro and in vivo quantitation of sunitinib in glioblastoma cells and cancer patients-Reference-Cited by-同舟云学术

Development of a validated LC-MS/MS method for the in vitro and in vivo quantitation of sunitinib in glioblastoma cells and cancer patients

Published:2019-02 Issue: Volume:164 Page:690-697
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Chatziathanasiadou Maria V.^ORCID,Stylos Evgenios K.,Giannopoulou Efstathia,Spyridaki Maria-Helen,Briasoulis Evangelos,Kalofonos Haralabos P.,Crook Tim,Syed Nelofer,Sivolapenko Gregory B.,Tzakos Andreas G.^ORCID

Funder

Blood Donation Center of the University Hospital of Ioannina

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference64 articles.

1. Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles;Di Gion;Clin. Pharmacokinet.,2011

2. Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects;Kollmannsberger;Can. Urol. Assoc. J.,2007

3. Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies;Papaetis;BioDrugs,2009

4. Phase 2 study of sunitinib in patients with metastatic mucosal or acral melanoma;Buchbinder;Cancer,2015

5. Biomarker analysis in a phase II study of sunitinib in patients with advanced melanoma;Decoster;Anticancer Res.,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization and optimization of magnetic molecularly imprinted nanofibers for determination of sunitinib in human serum and capsule samples;Talanta;2024-11

2. Chromatographic and mass spectrometric analytical strategies for profiling tyrosine kinase inhibitors in biological samples;Microchemical Journal;2024-06

3. Comprehensive Review on Analytical and Bioanalytical Methods for Quantification of Anti-angiogenic Agents used in Treatment of Cervical Cancer;Current Pharmaceutical Analysis;2023-12

4. An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma;Cancers;2021-04-18

5. Analysis of sunitinib malate, a multi-targeted tyrosine kinase inhibitor: A critical review;Microchemical Journal;2021-04